The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.70
Bid: 32.00
Ask: 33.40
Change: 0.00 (0.00%)
Spread: 1.40 (4.375%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 32.70
MERC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Three additional university partnerships

15 Dec 2015 07:00

RNS Number : 0360J
Mercia Technologies PLC
15 December 2015
 



RNS Reach

15 December 2015

 

Mercia Technologies PLC

Further expansion into the North of England with three additional university partnerships

Mercia Technologies PLC (AIM: MERC, "Mercia"), a Midlands-based investment group building, funding and commercialising technology businesses in the UK, has further expanded its operations into the North of England, through university partnerships with the University of York, the University of Liverpool and Liverpool John Moores University. This takes the total of Mercia's university partnerships to 14, across the Midlands, the North of England and Scotland.

The three new university partnerships will provide further opportunities for Mercia to tap into the wealth of early stage technology businesses available in the North of England.

Mercia has already expanded its operations to Scotland, with the opening of an Edinburgh office, alongside two partnerships with the University of Strathclyde and Abertay University, announced on 27 October 2015. Mercia plans to open an office in the North of England in order to work more closely with its partner universities within the region in 2016.

Commenting on the partnerships, Mark Payton, CEO of Mercia Technologies PLC, said:

"Since Mercia Technologies listed on AIM last year, we have seen the number of our university partnerships increase from 9 to 14. At the same time, our third-party funds under management through Mercia Fund Management ("MFM") have grown markedly, enabling us to provide seed and early stage investment capital for a growing portfolio of exciting technology-backed businesses with high growth potential.

"Through our Complete Capital Solution we are able to support young and growing businesses via MFM with the potential over the medium to long term to provide material direct investment from Mercia Technologies PLC.

"The North of England has a wealth of untapped potential in terms of scalable technology businesses, and we look forward to working closely with the technology transfer teams at each of our new university partners to build, fund, and support the accelerated growth of their promising spinout companies."

For further information contact:

 

Mercia Technologies PLC (www.merciatechnologies.com)

+44 (0) 330 223 1430

Mark Payton, Chief Executive

Martin Glanfield, Chief Financial Officer

Cenkos Securities

+44 (0) 20 7397 8900

Ivonne Cantu / Mark Connelly (NOMAD)

Instinctif Partners

+44 (0) 20 7457 2020

Kay Larsen / Lauren Foster

 

 

 

Note to editors

Mercia creates, funds and develops technology businesses nationally with an emphasis on the Midlands, the North of England and Scotland. The Group facilitates technology transfer, company formation, incubation, commercialisation and investment, with approximately 50% of its investments being university spinouts. Mercia invests across technology sectors in which it has deep sector expertise.

 

The Mercia model is one of patiently nurturing businesses via its third party funds under management and then scaling them with direct investment at the point of commercial traction. Through this, Mercia has a well seeded portfolio and pipeline of investments - its 'emerging stars'.

 

Mercia's shares started trading on AIM on 18 December 2014 and since then up until 3 December 2015, Mercia has invested over £20.0million directly across its portfolio of emerging stars, which in themselves have attracted total investment of approximately £70.0million alongside Mercia and its third party funds. In addition to its direct investments, Mercia (via MFM's funds under management) has invested over £20.0million to build its portfolio of potential future emerging stars.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAAALFENSFAF
Date   Source Headline
2nd Dec 20207:00 amRNSPerformance fee entitlement
1st Dec 20207:00 amRNSInterim Results
27th Nov 20207:00 amRNSInvestor Presentation
6th Nov 20207:00 amRNSNotice of Results and Investor Presentations
3rd Nov 20207:00 amRNSBoard Appointment
30th Oct 20207:30 amRNSNew direct investment into Sense Biodetection
19th Oct 20207:00 amRNSSuccessful exit of Clear Review
7th Oct 20207:00 amRNSWarwick Acoustics Update
25th Sep 20207:00 amRNSDirector/PDMR Dealings
24th Sep 202010:29 amRNSResult of AGM
24th Sep 20207:00 amRNSAGM Statement
18th Sep 20207:00 amRNSLife Sciences’ Portfolio Update
24th Aug 20207:00 amRNSGrant of Options
31st Jul 20207:03 amRNSPublication of Annual Report
29th Jul 20202:31 pmRNSDirector/PDMR Dealings
14th Jul 20207:00 amRNSPreliminary results
9th Jul 20207:00 amRNSSale of The Native Antigen Company
1st Jul 20207:00 amRNSPortfolio company MIP Diagnostics raises £5.1m
11th Jun 20207:00 amRNSNotice of Results
27th May 202011:08 amRNSMercia accredited by BBB under CBILS
14th May 20207:00 amRNSMedherant partners with Cycle Pharmaceuticals
6th May 20207:00 amRNSInvestment into OXGENE
21st Apr 20207:00 amRNSBritish Business Bank increases Mercia’s mandate
3rd Apr 202012:47 pmRNSNVM VCTs raise £38.2 million
2nd Apr 20207:00 amRNSPortfolio companies collaborate against COVID-19
27th Mar 202011:30 amRNSDirector/PDMR Dealings
25th Mar 20203:08 pmRNSCOVID-19 Business Update
25th Mar 20201:42 pmRNSNotification of Major Holdings
18th Mar 202010:59 amRNSNOTIFICATION OF MAJOR HOLDINGS
11th Mar 20204:18 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSNOTIFICATION OF MAJOR HOLDINGS
4th Feb 20203:20 pmRNSPDMR / Director Dealings
4th Feb 20208:50 amRNSNotification of Major Holdings
4th Feb 20207:00 amRNSHolding in Company
29th Jan 20207:00 amRNSGrant of Options
22nd Jan 202012:49 pmRNSForm 8.3 - RedX Pharma PLC
17th Jan 20204:45 pmRNSNotification of Major Holdings
16th Jan 20207:00 amRNSnDreams makes continuing commercial progress
9th Jan 20202:06 pmRNSNOTIFICATION OF MAJOR HOLDINGS
9th Jan 20202:00 pmRNSNOTIFICATION OF MAJOR HOLDINGS
31st Dec 201910:55 amRNSNotification of Major Holdings
30th Dec 201911:57 amRNSNOTIFICATION OF MAJOR HOLDINGS
30th Dec 201911:36 amRNSNOTIFICATION OF MAJOR HOLDINGS
27th Dec 201912:01 pmRNSNOTIFICATION OF MAJOR HOLDINGS
24th Dec 201912:16 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20193:36 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:14 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20192:04 pmRNSCompletion of Acquisition
23rd Dec 201912:44 pmRNSNOTIFICATION OF MAJOR HOLDINGS
23rd Dec 20199:49 amRNSDirector/PDMR Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.